Renal Cell Carcinoma
Conditions
Interventions
Observation group:None
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with bilateral renal cell carcinoma confirmed by imaging and pathology. 2. Bilateral tumors were surgically treated in our hospital. 3. Complete clinical and follow-up data. 4. The paraffin-embedded pathological specimens were well preserved.
Exclusion criteria
Exclusion criteria: 1. Hereditary bilateral renal cell carcinoma. 2. Patients with unilateral multiple renal tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oncologic parameters (date of tumor discovery, tumor volume, TNM stage, pathological type, etc.);Treatment information (including type of surgery, date of surgery for bilateral tumors, neoadjuvant/adjuvant treatment information, etc.);Whole exome sequencing of postoperative paraffin-embedded pathological specimens from patients with bilateral renal cell carcinoma;Prognosis of Tumors (time of tumor recurrence and metastasis, number and organs of recurrence and metastasis, time and cause of death);Surgical Data (surgical approach, duration of surgery, estimated blood loss, transfusion status, perioperative complications, etc.).; | — |
Secondary
| Measure | Time frame |
|---|---|
| Epidemiological information(Age, gender, past history, family history, etc);Postoperative follow-up data; | — |
Countries
China
Contacts
Public ContactMa Lulin
Peking University Third Hospital
Outcome results
None listed